Request Demo
Last update 25 Jan 2025
177Lu-LNC1008
Last update 25 Jan 2025
Overview
Basic Info
Drug Type Chemical drugs, Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals |
Synonyms 177Lu-LNC1008 |
Target |
Mechanism αvβ3 modulators(Integrin alpha-V/beta-3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with 177Lu-LNC1008CTR20242716
评价177Lu-LNC1008注射液在整合素alpha-v beta-3（αvβ3）阳性的晚期恶性实体瘤患者中的安全性、耐受性、药代动力学、辐射剂量学和初步疗效的I期临床试验
[Translation] A phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry and preliminary efficacy of 177Lu-LNC1008 injection in patients with advanced malignant solid tumors positive for integrin alpha-v beta-3 (αvβ3)
100 Clinical Results associated with 177Lu-LNC1008
Login to view more data
100 Translational Medicine associated with 177Lu-LNC1008
Login to view more data
100 Patents (Medical) associated with 177Lu-LNC1008
Login to view more data
100 Deals associated with 177Lu-LNC1008
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 29 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free